CROI 2019
The annual Conference on Retroviruses and Opportunistic Infections (CROI) was held in Seattle, USA from 4 to 7 March 2019.
-
4-7 March 2019
-
Seattle, USA
Young people born with HIV more likely to have “mild” verbal memory test deficits if they have ever had an AIDS-defining condition
Monoclonal antibody may lead to long-term viral load reduction
Clusters of co-morbidities in people living with HIV show major non-HIV medical needs
Epidemic of sexually transmitted hepatitis C in gay men now involves both HIV-positive and HIV-negative men
Opioid overdose deaths are rising among people with HIV in the United States
Non-adherence to HIV treatment for cost-saving reasons reported by 8% in American study
Partners of transgender women form a separate HIV risk group, Peruvian study finds
Urine test can provide accurate point-of-care results about PrEP adherence
TAF: Quick-dissolve combination PrEP insert is effective against HIV infections in monkeys; intermittent solo pill less so
Dolutegravir-based second-line ART achieves excellent virological outcomes even in the presence of resistance to recycled NRTIs
Higher HIV viral load and lower CD4 count linked to liver cancer risk
Thailand’s achievements in HIV are not all widely implemented
‘Gentler cure’ technique produces delay in viral rebound in some people taken off HIV therapy
U=U is a human rights issue
People with HIV may benefit from earlier lung cancer screening
Self-testing helps the partners of people with HIV to test, but not to link to care
Co-administration of dolutegravir-based treatment and short course of rifapentine/isoniazid (3HP) well tolerated in people living with HIV
Sixfold increased risk of infant HIV infection and high rates of low birth weight among women with HIV/hepatitis B co-infection